Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • EGFR
    (120)
  • HER
    (16)
  • Apoptosis
    (12)
  • Autophagy
    (10)
  • Src
    (8)
  • FGFR
    (6)
  • PDGFR
    (6)
  • VEGFR
    (6)
  • BTK
    (4)
  • Tyrosine Kinases
    (4)
Filter
Search Result
Results for "

ErbB-1

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    125
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    4
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    10
    TargetMol | Natural_Products
  • Recombinant Protein
    43
    TargetMol | Recombinant_Protein
  • Antibody Products
    41
    TargetMol | Antibody_Products
Trastuzumab
T9912180288-69-1
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2. Trastuzumab has been clinically used to treat HER2 Positive Metastatic Breast Cancer and HER2 Positive Gastric Cancer.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Cetuximab
Cetuximab (anti-EGFR), C225
T9905205923-56-4
Cetuximab (C225) is a monoclonal antibody that is an inhibitor of human epidermal growth factor receptor (EGFR) (Kd=0.201 nM). Cetuximab has antitumor activity, inhibiting tumor cell proliferation and inducing apoptosis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Hot
Matuzumab
EMD-72000, EMD72000, EMD 72000
T9922339186-68-4
Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR with potential anticancer activity that blocks EGFR activation and downstream signaling for the study of non-small cell lung cancer.
  • Inquiry Price
Size
QTY
Panitumumab
Panitumumab(anti-EGFR)
T9927339177-26-3
Panitumumab is a fully human IgG2 monoclonal antibody targeting the epidermal growth factor receptor EGFR).
  • Inquiry Price
Size
QTY